Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

AbbVie’s HIV therapy Kaletra fails to show efficacy in COVID-19

Drug failed to improved condition of hospitalised COVID-19 patients

- PMLiVE

Pfizer and BioNTech’s COVID-19 vaccine begins EMA evaluation

Vaccine is the second to undergo EMA's 'rolling review' process after AstraZeneca/Oxford Uni's candidate

- PMLiVE

Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm

Perlmutter is set to join the board of AI drug discovery biotech Insitro

- PMLiVE

Multilingual remote conferencing and interpreting platforms in the era of COVID-19

Turning the pharmaceutical language behind vaccine development into engaging, accessible content

- PMLiVE

A day in the life of Becca McConnell a Senior Account Executive

We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.

OPEN Health

- PMLiVE

The flexible salesforce

By John Procter

- PMLiVE

The importance of pharma intelligence in setting brand strategy

Looking at the different approaches that can be leveraged to assess the competition

- PMLiVE

Nearly 16,000 coronavirus cases left out of UK’s daily figures between 25 September and 2 October

PHE chief exec says ‘technical issue’ caused unreported coronavirus cases

- PMLiVE

Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November

Company will seek emergency use authorisation for experimental vaccine

- PMLiVE

CEPI establishes global network to compare COVID-19 vaccines

Network will include the UK, Canada, the Netherlands, Italy, Bangladesh and India

- PMLiVE

TikTok and diabetes awareness

The video-sharing platform TikTok has been fostering huge numbers of people documenting the day-to-day reality of their health conditions. From comedy snippets about diagnosis to personal reviews of health tech,...

11 London

- PMLiVE

EMA begins rolling review of AZ’s COVID-19 vaccine candidate

Agency has started evaluating data from non-clinical laboratory studies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links